REPORT.

SEC. 1114. REPORT. Not later than January 1, 2012, the Comptroller General of the United States shall submit a report to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives that examines whether and how this subtitle has—(1) encouraged the development of new antibiotics and other drugs; and121 STAT. 978(2) prevented or delayed timely generic drug entry into the market.